Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Mankind Pharma Ltd - 543904 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company will be held on 30th May 2023, inter-alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on 31st March 2023. Further, in continuation of our earlier letter dated 9th May 2023 under subject 'Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s ''Code of Conduct for Prevention of Insider Trading'', the trading window for dealing in the securities of the Company shall remain closed upto 48 hours after the declaration of the Financial Results of the Company for the quarter and financial year ended on 31st March 2023.
22-05-2023
Bigul

Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('The Listing Regulations')-Update

 This is with reference to the captioned subject and in relation to our previous communications dated May 11, 2023 and May 12, 2023. We would like to intimate that Income Tax Department ('IT Dept') conducted search under the Income Tax Act, 1961 at some of the offices and plants of the Company and its subsidiaries. We have fully cooperated with the officials of IT Dept during the proceedings and responded to the clarifications and details sought by them. We will continue to provide any further clarification/information that may be required. The business operations of the Company continue as usual and have not been impacted due to the search. We will comply with legal obligation in relation to disclosure from time to time.
17-05-2023
Bigul

Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('The Listing Regulations') - Update

 This is with reference to the captioned subject, we would further like to update you about the ongoing search of the Income Tax Department ('IT Dept'). This is to inform you that the IT Dept is conducting search at the offices of the Company located in New Delhi and Navi Mumbai, at the plants of the Company located at Paonta Sahib, Himachal Pradesh and South Sikkim, Sikkim, and at the plants of Relax Pharmaceuticals Private Limited, Copmed Pharmaceuticals Private Limited and Pharmaforce Labs (subsidiaries of the Company), located at Paonta Sahib, Himachal Pradesh. The officials of the Company and subsidiaries are cooperating with the officials of the IT Dept and are responding to the queries raised by them. The updates provided hereinabove are provided based on and to the extent of the information available with the Company at the time of writing this letter. Once the search by the IT Dept concludes, the Company will update the Stock Exchanges in case of any material information/event
12-05-2023
Bigul

Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('The Listing Regulations')

 Pursuant to Regulation 30 of the Listing Regulations and in terms of the Policy for Determination of Materiality of Events or Information of the Company, we hereby inform you that the Income Tax Department is conducting a search at some of the premises/ plants related to the Company and some of its subsidiaries. The officials of the Company and its subsidiaries are cooperating with the officials of the Income Tax Department and are responding to the queries raised by them. This has had no impact on our operational performance. This is the only information that we are able to provide at this stage. Once the search by the Income Tax Department concludes, the Company will update the Stock Exchanges in case of any material information/ event. Mankind Pharma Limited is an ethical and law abiding Company and follows the best corporate governance practices. We are extending our full cooperation to the officials of the Income Tax Department in this regard.
11-05-2023
Bigul

Mankind Pharma Ltd - 543904 - Clarification sought from Mankind Pharma Ltd

 The Exchange has sought clarification from Mankind Pharma Ltd on May 11, 2023, with reference to news appeared in economictimes.indiatimes.com dated May 11, 2023 quoting"I-T dept raids Mankind Pharma premises in Delhi over tax evasion allegation"The reply is awaited.
11-05-2023
Bigul

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Resignation of Director

 As per terms of the shareholders agreement dated April 06, 2018 (as amended on March 24, 2022 and August 08, 2022) ('Shareholders Agreement') executed between the Company, promoters of the Company, Cairnhill CIPEF Limited ('CIPEF'), Cairnhill CGPE Limited ('CGPE'), Beige Limited ('Beige') and Link Investment Trust ('Link' and collective with CIPEF, CGPE and Beige referred to as 'Investors'), the Investors had a right to nominate Director on Board of the Company basis their shareholding in the Company. Further, as per terms of the aforesaid Shareholders Agreement and upon listing of equity shares of the Company on BSE Limited and National Stock Exchange of India Limited ('Stock Exchanges'), said Shareholders Agreement stands terminated. Accordingly, Mr. Leonard Lee (DIN: 07379167) a director representing CIPEF and CGPE on the Board of Directors of the Company has tendered his resignation with effect from 9th May 2023.
09-05-2023
Bigul

Mankind Pharma Ltd - 543904 - Closure of Trading Window

 Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's 'Code of Conduct for Prevention of Insider Trading', the trading window for trading in securities of the Company by Designated Persons (along with their immediate relatives and/ or persons with whom they share material financial relationship), has been closed from April 24, 2023 till 48 hours after the declaration of financial results of the Company for the quarter and year ended March 31, 2023. The date of Board Meeting for declaration of financial results of the Company for quarter and year ended on March 31, 2023 will be intimated in due course. You are requested to take the same on records.
09-05-2023
Bigul

Mankind Pharma Ltd - 543904 - Listing of equity shares of Mankind Pharma Ltd

 Trading Members of the Exchange are hereby informed that effective from May 09, 2023, the equity shares of Mankind Pharma Ltd (Scrip Code: 543904) are listed and admitted to dealings on the Exchange in the list of ''B'' Group Securities. For further details please refer to the notice no 20230508- dated May 08, 2023.
09-05-2023
Close

Let's Open Free Demat Account